Skip to content
Review

Abstract 14507: Conduction System Pacing via True Left Bundle Branch Capture versus Biventricular Pacing in Heart Failure Patients Requiring Cardiac Resynchronization Therapy A Systematic Review and Meta Analysis

Nov 2026 · Circulation · 0 citations

Abstract

Introduction: Biventricular pacing (BiVP) is established cardiac resynchronization therapy (CRT) for heart failure with reduced ejection fraction (HFrEF), yet 30-45% of patients fail to respond. True left bundle branch pacing (LBBP) achieves resynchronization through direct His-Purkinje capture and may offer superior outcomes. Prior meta-analyses are limited by inclusion of non-selective left ventricular septal pacing; this review restricted inclusion to confirmed true LBBP. Hypothesis: True LBBP reduces all-cause mortality, heart failure hospitalization, and composite clinical endpoints compared with BiVP, and produces superior echocardiographic response and ventricular remodeling in patients undergoing CRT. Methods: Systematic review and meta-analysis of randomized controlled trials (RCTs) and prospective cohort studies identified through PubMed, Embase, and Cochrane Library (inception-March 2026). Only studies confirming true left bundle branch conduction system capture with a concurrent BiVP comparator were included. Pooled risk ratios (RR) and mean differences (MD) with 95% CIs were calculated using DerSimonian-Laird random-effects models. Heterogeneity was quantified by I2. Evidence certainty was assessed via GRADE. Protocol was pre-registered (PROSPERO CRD420261389229). Results: Six studies (2 RCTs, 4 prospective cohort; n=1,001; LBBP n=403, BiVP n=598; follow-up 6-36 months) were included. LBBP significantly reduced all-cause mortality (RR 0.49; 95%CI 0.32-0.75; P=0.001; I2=0%), heart failure hospitalization (RR 0.27; 95%CI 0.20-0.37; P<0.001; I2=0%), and composite outcome (RR 0.35; 95%CI 0.26-0.46; I2=4%). Echocardiographic super-response was markedly higher with LBBP (RR 1.82; 95%CI 1.41-2.36; I2=13%; GRADE: high certainty). LVEF improvement was significantly greater (MD +5.08%; 95%CI 3.98-6.18; I2=4%). QRS duration was significantly shorter with LBBP (MD -18.82 ms; I2=92%); sensitivity analyses confirmed a consistent direction of effect. GRADE certainty was low for primary clinical outcomes and very low for most continuous parameters. Conclusions: True LBBP is associated with significant reductions in all-cause mortality, heart failure hospitalization, and composite outcomes, with superior echocardiographic super-response and LVEF improvement versus BiVP. These findings support LBBP as a clinically promising CRT strategy; confirmation by adequately powered RCTs is required before first-line guideline adoption

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.